Haas T, Innerhofer P, Klingler A, Wagner-Berger H, Velik-Salchner C, Streif W, Fries D
Innsbruck Medical University, Department of Anaesthesiology and Critical Care Medicine, Anichstrasse, Innsbruck, Austria.
Eur J Anaesthesiol. 2008 Jun;25(6):473-8. doi: 10.1017/S0265021508003736. Epub 2008 Feb 26.
Patients exhibiting considerable blood loss are prone to develop dilutional coagulopathy following volume supply. In such patients, in addition to transfusing stored blood components, cell saver systems are used to minimize allogeneic transfusion. Since red cell transfusion might influence the haemostatic system by further dilution, we investigated the effects of re-transfusion of salvaged washed red blood cells on the haemostatic process in an animal model of controlled haemorrhage using rotational thrombelastometry (ROTEM; Pentapharm Co., Munich, Germany).
Anaesthetized pigs (n = 20) developed coagulopathy following haemorrhagic shock (withdrawal of 66% of estimated blood volume) and volume resuscitation with 6% hydroxyethyl starch 130/0.4. The shed blood was processed in a Cellsaver device (CATS; Fresenius AG, Bad Homburg, Germany), and the resulting salvaged red blood cells were re-transfused. ROTEM assays were performed at baseline, after blood loss, after volume resuscitation and following re-transfusion of salvaged red blood cells.
As compared with baseline, blood loss and subsequent volume resuscitation resulted in significantly increased median values of clotting time (CT: 47.0, 5 .3 and 103.5 s), and clot formation time (CFT: 36.0, 40.0 and 186.0 s), whiggle maximum clot firmness decreased (MCF: 72.0, 68.5 and 39.5 mm). After re-transfusion of salvaged red blood cells (805 +/- 175 mL) all these parameters improved (CT: 80.5 s; P = 0.05, CFT: 144.0 s; P = 0.0008, MCF: 42.0 mm; P = 0.0019) although baseline values were not reached.
In the case of extreme isovolaemic haemodilution, increasing the circulating red cell mass by re-transfusing salvaged red blood cells did not worsen the findings of dilutional coagulopathy but interestingly, at least partially, improves the clot formation process.
大量失血的患者在补充血容量后易发生稀释性凝血障碍。对于这类患者,除输注库存血液成分外,还使用血液回收系统以尽量减少异体输血。由于红细胞输注可能通过进一步稀释而影响止血系统,我们使用旋转血栓弹力图(ROTEM;德国慕尼黑Pentapharm公司)在可控出血动物模型中研究了回输回收洗涤红细胞对止血过程的影响。
对20只麻醉猪进行失血性休克(抽取估计血容量的66%)并使用6%羟乙基淀粉130/0.4进行容量复苏,从而导致凝血障碍。将流出的血液在血液回收装置(德国巴特洪堡费森尤斯公司的CATS)中进行处理,然后回输得到的回收红细胞。在基线、失血后、容量复苏后以及回输回收红细胞后进行ROTEM检测。
与基线相比,失血及随后的容量复苏导致凝血时间(CT:分别为47.0、5.3和103.5秒)、凝血形成时间(CFT:分别为36.0、40.0和186.0秒)的中位数显著增加,而摆动最大凝血硬度降低(MCF:分别为72.0、68.5和39.5毫米)。回输回收红细胞(805±175毫升)后,所有这些参数均有所改善(CT:80.5秒;P = 0.05,CFT:144.0秒;P = 0.0008,MCF:42.0毫米;P = 0.0019),尽管未达到基线值。
在极端等容性血液稀释的情况下,通过回输回收红细胞增加循环红细胞量并不会使稀释性凝血障碍的表现恶化,有趣的是,至少部分地改善了凝血形成过程。